Advanced stage Hodgkinʼs lymphoma 2024—Update on first line treatment
Crossref DOI link: https://doi.org/10.1007/s12254-024-00990-w
Published Online: 2024-09-13
Published Print: 2024-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lehner, Barbara
Panny, Michael
Text and Data Mining valid from 2024-09-01
Version of Record valid from 2024-09-01
Article History
Received: 9 May 2024
Accepted: 28 July 2024
First Online: 13 September 2024
Conflict of interest
: B. Lehner and M. Panny received honoraria from Takeda.